1. Home
  2. CCU vs NVAX Comparison

CCU vs NVAX Comparison

Compare CCU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compania Cervecerias Unidas S.A.

CCU

Compania Cervecerias Unidas S.A.

HOLD

Current Price

$11.71

Market Cap

2.2B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.72

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCU
NVAX
Founded
1850
1987
Country
Chile
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.6B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
CCU
NVAX
Price
$11.71
$7.72
Analyst Decision
Strong Sell
Hold
Analyst Count
2
9
Target Price
$12.00
$11.33
AVG Volume (30 Days)
241.3K
3.7M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$9.69
N/A
Revenue Next Year
$6.15
N/A
P/E Ratio
$18.35
$3.10
Revenue Growth
N/A
64.69
52 Week Low
$10.71
$5.01
52 Week High
$15.75
$11.85

Technical Indicators

Market Signals
Indicator
CCU
NVAX
Relative Strength Index (RSI) 45.28 32.09
Support Level $11.51 $6.35
Resistance Level $12.38 $8.45
Average True Range (ATR) 0.36 0.54
MACD 0.12 -0.28
Stochastic Oscillator 81.07 4.45

Price Performance

Historical Comparison
CCU
NVAX

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: